Professional Documents
Culture Documents
GLOBAL PERSPECTIVE
Paul L
L. Pluta,
Pluta PhD
Journal of Validation Technology and Journal of GXP Compliance
University of Illinois at Chicago (UIC) College of Pharmacy
Chicago, IL, USA
1
OUTLINE
OVERVIEW OF IDENTIFIED PROBLEMS
PRODUCT PROBLEMS
Residue chemistry as basis for cleaning
Solubility in worst
worst-case
case residue determination
Cleanability in worst case residue determination
EQUIPMENT-RELATED PROBLEMS
Non-uniform contamination transfer
Most difficult-to-clean locations
LABORATORY PROBLEMS
Residue stability in cleaning residue analysis
Residue recovery studies
Swab sampling technique, reliability, and training
2
OVERVIEW
CLEANING VALDIATION PROBLEMS
3
AUDIT QUESTIONS
Is residue chemistry considered in developing cleaning procedure?
Is pH-solubility profile considered in worst-case matrix analysis?
Is residue cleanabilityy considered in worst-case residue
determination?
Is non-uniform contamination considered in residue calculations?
Are most difficult
difficult-to-clean
to clean equipment locations proceduralized?
Are manual cleaning personnel qualified and requalified?
Are cleaning procedures quantitative and documented?
A di
Are dirty
t hhold
ld ti
times controlled?
t ll d?
Is residue stability considered in cleaning residue analytical?
Have analytical recovery studies been conducted? On
representative materials?
Are swab sampling personnel trained / qualified?
4
LIFECYCLE APPROACH TO CLEANING VALIDATION
FDA identified three stages of process validation
1. Process design and development (understanding)
2 Process
2. P qualification
lifi ti ((performance)
f )
3. Continued process verification (maintenance)
5
LIFECYCLE APPROACH TO PROCESS VALDIATION
KEY CONCEPTS
Stage approach
Design and development
General approaches
Specific cleaning methods
Process demonstration
Continued process verification
Scientific and technical basis
Risk
Variation identification and control
6
1. PRODUCT RESIDUE PROBLEMS
7
PHYSICAL AND CHEMICAL PROPERTIES OF
RESIDUE AS BASIS FOR CLEANING
8
PHYSICAL AND CHEMICAL PROPERTIES OF RESIDUE
BASIS FOR CLEANING PROCEDURE
Final method: Acid wash, alkaline soap wash, water, PurW, dry
Significant improvement
No residues. Unknown peaks determined to be flavors.
API dissolves (acid-base neutralization)
10
PHYSICAL AND CHEMICAL PROPERTIES OF RESIDUE
BASIS FOR CLEANING PROCEDURE
C
Case study
t d #2
#2: S
Smallll molecule
l l API orall liliquid
id product
d t . API iinsoluble
l bl
Original cleaning method
Alkaline cleaningg agent
g with manual intervention
Acid cleaning agent (full strength) when white residue noted.
Small parts soaked in acid cleaning agent (full strength)
Cleaning method difficult,
difficult ineffective,
ineffective and unsafe
Liquid product alcohol / glycol solvent system
Change g cleaningg method to alcohol initial rinse. API soluble
Final method: Alcohol rinse/soak, alkaline wash, water, PurW, dry
Significant improvement
No residues
Easy and safe method
Consider active drug and other residue chemistry in development
of cleaning process
11
EXPERIMENTAL DEVELOPMENT PROCEDURE
1. Evaluate formulation and chemical properties
2. Laboratory comparison 2 L beaker and mixer
Small amount of product into beaker + water to disperse
Add cleaning agents to be screened acid, neutral, alkaline,
solvent
Visual observation
3. Coupons with residue in beaker
4 Simulated
4. Si l t d cleaning
l i procedure.
d
Swab sampling
Analytical
y determination
5. Conclusions and recommendations
6. Confirmation in pilot equipment
12
CLEANING PROCEDURE DEVELOPMENT PROCESS
Stage 1 R&D
1. API technical analysis.
2. pH solubility profile pH 1-12.
3. Solubility in proposed cleaning liquid.
4. pH-stability profile pH 1-12.
5. Laboratory cleaning studies confirmation.
6. Analytical method development based on stability data.
7
7. Testing of all excipients with analytical method
method.
Source of unknown peaks
14
BIOTECH CLEANING CHEMISTRY GROWTH MEDIUM
Medium Composition
Acids or bases
Monovalent salts
Polyvalent salts
Amino acids
Proteins (polypeptides)
Carbohydrates
Aqueous
q soluble organics
g
Non-aqueous soluble organics
15
CLEANING AGENT OPTIONS
Water
Commodityy alkalis and acids
Organic solvents
Surfactants
Anionic
Cationic
Amphoteric
Nonionic
Formulated detergents
16
COMPONENTS OF FORMULATED DETERGENTS
Surfactants
Alkalis
A id
Acids
Sequestrants / chelants
Dispersants / anti-redeposition agents
Corrosion inhibitors
Oxidizing
g agents
g
Enzymes
Buffers / builders
Preservatives
17
RESIDUE SOLUBILITY IN MOST DIFFICULT TO CLEAN MATRIX
BASIS FOR CLEANING PROGRAM
18
pH SOLUBILITY
p SO U PROFILE,
O , pH
p 1-12
Solubility
mg/ml
Drug A
Drug B
pH 1 7 12
19
SULFAMETHOXAZOLE pH-SOLUBILITY
Amount
Dissolved
Note pKa
1 pH
p 12
20
CLEANING MATRIX
Determine Worst-Case Soil
SOLUBILITY (mg / ml)
pH
H1 W t
Water pH
H 12 Alkaline
Alk li
Cleaning Agent
Drug A 25 25 25 25
Drug B 15 15 15 15
Drug D 150 10 10 50
21
CLEANABILITY IN DETERMINING
MOST DIFFICULT-TO-CLEAN
DIFFICULT TO CLEAN RESIDUE IN MATRIX
22
CLEANABILITY IN DETERMINATING MOST
DIFFICULT TO CLEAN RESIDUE IN MATRIX
DIFFICULT-TO-CLEAN
Other considerations
Solubility in cleaning liquid
Toxicity
Concentration in dosage g form
Cleanability
Formulation components major effect
Cl
Cleaning
i personnell iinputt
Dirty hold time
Soil-surface interactions (e.g., air-liquid interface)
23
CLEANABILITY IN DETERMINATING MOST
DIFFICULT TO CLEAN RESIDUE IN MATRIX
DIFFICULT-TO-CLEAN
IR Tablet ER Tablet
API API
Microcrystalline cellulose Same
L t
Lactose Same
S
--- Wax
--- Cellulosic polymer
Crospovidone ---
Talc Same
Magnesium stearate Same
24
OTHER CONSIDERATIONS
Consider flavor and color oils
Dyes/lakes
D /l k may b be more diffi
difficultl to clean
l
than active drug
Consider solubility of all components
Alcohol explosivity
p y
Solvent toxicity
25
2. EQUIPMENT PROBLEMS
26
NON-UNIFORM CONTAMINATION TRANSFER
PROBLEM: Non-uniform contamination not considered
Cleaning Processes
1. Make product A
2. Clean
3. Make product B. Remaining Product A residue contaminates
Product B
Equipment categorization
Uniform contamination equipment
Equipment with all contamination uniformly transferred.
Example: Mixing tank
Non-uniform contamination equipment
Example: Filling needles, compressing machine.
27
NON-UNIFORM CONTAMINATION
1. Make 50 L tank of lemonade.
2. Fill 2 L pitcher from tank.
3. Fill cups from pitcher
4. Clean tank and pitcher.
5. Make ice tea in 50 L tank All lemonade residue in tank uniformly
transferred to ice tea.
6. Fill 2 L pitcher from
f tank All lemonade residue in pitcher transferred
f to
ice tea. Fill cups. HIGHEST LEVEL OF CONTAMINATION.
7. Fill same 2 L pitcher from tank Much less lemonade residue left in
pitcher transferred to ice tea
tea. Fill cups
cups.
8. Fill same 2 L pitcher from tank Even less lemonade residue in pitcher
transferred to ice tea. Fill cups.
9. And so on..
R id lilimit
Residue it = Min
Mi ddose A x B
Batch
t h size
i BxS Safety
f t ffactor
t
Max dose B x Surface area
References:
Fourman and Mullen. Pharmaceutical Technology 17, #4, 1993.
LeBlanc. Validated Cleaning Technologies for Pharmaceutical Manufacturing.
Interpharm/CRC Press, 2000.
29
EQUIPMENT TO BE CLEANED
SAMPLING LOCATIONS
UNIFORM AND NON
NON-UNIFORM
UNIFORM CONTAMINATION
Product A = X
Product B = X
Product B flushes filling lines with A residue
xxxxxxxxxx x x x x x x x
xxxxxxxxxx x
xxxxxxxxxx x
xxxxxxxxxx
xxxxxxx
MANUFACTURING TANK PRODUCT
30
NON-UNIFORM CONTAMINATION CALCULATION
Residue non-uniformly flushed into initial product units
Reference:
LeBlanc.
L Bl V lid t d Cleaning
Validated Cl i T Technologies
h l i ffor Ph
Pharmaceutical
ti l MManufacturing.
f t i
Interpharm/CRC Press, 2000.
31
NON-UNIFORM CONTAMINATION
Contaminated product may be eliminated
p
in set-up.
Sites must be prepared to answer
questions from auditors based on
calculations.
32
MOST-DIFFICULT-TO-CLEAN
EQUIPMENT LOCATIONS
33
MOST DIFFICULT TO CLEAN EQUIPMENT
LOCATIONS
Equipment Technical Evaluation
Deadlegs
Corners
Undersides
Pipe bends
Flow velocity
Coverage studies
Drainability
Other considerations (e.g., baseline visual inspection)
34
PROCEDURE TO DETERMINE SAMPLING LOCATIONS
35
SAMPLING PAGES
DIGITAL PICTURES
One
O sampling li page ffor each h equipment
i t
Assemble pages for process train
All pages in cleaning validation protocol
Arrows for specific sampling locations
Random locations unspecified
Use for all cleaning validation
36
EQUIPMENT SAMPLING INSTRUCTIONS FOR CLEANING VALIDATION
EQUIPMENT: IMPACT MILL
PRODUCT
EQUIPMENT SAMPLING
CONTACT SAMPLE TYPE RATIONALE
LOCATION
MATERIAL
Maximum residue accumulation.
1. Rotor Stainless Steel Swab
Maximum product contact
Maximum residue accumulation.
2. Screen Stainless Steel Swab
Maximum product contact
Maximum residue accumulation
3. Discharge Chute Stainless Steel Swab
Maximum product contact
X SAMPLED
EQUIPMENT ASSET# EQUIPMENT NAME LOCATION
2
1
3
37
3. CLEANING PROCESS PROBLEMS
Manual
M l cleaning
l i qualification
lifi ti
Manual cleaning is an inherently high risk activity.
Cleaning procedure documentation
Cleaning procedure documentation should be equivalent to
manufacturing process documentation -- Exact requirements with
personnel accountability.
accountability
Dirty hold time (time to initiate cleaning)
At lease one run at worst-case DHT
Worst-case DHT is not always longest DHT
Campaign length
Max number of lots must be controlled
Between lot procedure.
38
MANUAL
U C
CLEANING
G QU
QUALIFICATION
C O
39
MANUAL CLEANING
Manual cleaning procedures should be
monitored and maintained with increased
scrutiny compared to non-manual procedures
More frequent training of cleaning personnel
Increased supervision
Periodic (annual?) revalidation batches
40
MANUAL CLEANING -- Do you really know what is happening?
Q to operator: You cleaned the gasket with pure soap this is not the
procedure?
A: That is the only way to get it clean.
Q: So why dont you tell someone to change the procedure?
A: We dont have time.
41
MANUAL CLEANING -- Do you really know what is happening?
Q to
t operator:
t Why
Wh is
i there
th powder
d on th
the clean
l equipment?
i t?
A: Its clean enough.
Q to QA (equipment inspection person): Did you approve that the equipment
is clean?
clean?
A: Its clean enough.
Q to management: Do you know that your equipment is not clean?
A: Its
It s clean enough
enough.
43
CLEANING PROCEDURE DOCUMENTATION
(Cl
(Cleaning
i B Batch
t hRRecord)
d)
SOP
Fill tank
t k half
h lf full
f ll
Add half scoop of soap
Scrub as needed
Rinse until clean
Re-scrub and re-rinse if needed
44
CLEANING PROCEDURE DOCUMENTATION
(Cleaning Batch Record)
Fill tank with 500 L water. Sign/date __________
Add 20.0 kg cleaning agent. Sign/date __________
Disassemble Part A. Steps 1,2,3,4,5
Scrub for 20 minutes. Sign/date __________
Disassemble Part B. Steps 1,2,3,4,5
Soak Part B in cleaning liquid for 10 minutes. Sign/date __________
Rinse Part A and Part B with 50 L water. Sign/date __________
Rinse with 50 L Purified Water. Sign/date __________
Dry with compressed air
KEY POINTS
Exact concentration of cleaning agent liquid
Signature on quantitative steps
Grouping non-quantitative steps (e.g., disassembly)
45
DIRTY HOLD TIME
TIME TO INITIATE CLEANING
Residue
R id changes
h
Drying
Chemical changes
Physical changes
46
DIRTY HOLD TIME
47
LABORATORY STUDY DIRTY HOLD TIME
1. Develop simulated cleaning process
Coupon in beaker with stirrer
2 W
2. Weigh
i h coupons. Ali
Aliquott residue
id onto t coupon surface
f
per time schedule. Allow to air dry. Weigh coupons.
3. Example time schedule:
1-1-2014 Day 30
1-10-2014 Day 20
1-20-2014 Day 10
1-25-2014 Day 5
1-28-2014 Day 2
1-29 2014 Day 1
1 30 2014
1-30-2014 D 0
Day
49
4. LABORATORY PROBLEMS
Residue stability in cleaning residue analysis
Analytical methods must measure actual residues that are present.
50
ANALYTICAL METHOD DEVELOPMENT
PROBLEM: Analytical method does not
measure actual residues
Analytical method must measure actual residue
Small molecules
API
API degraded
g specific
p or non-specific
p method
Biotech molecules
API degraded
g non-specific
p method
(e.g., TOC or amino acid)
Solubility considerations
Hydrophilic and hydrophobic molecules
Ionization Effect of pH
Effect of temperature
Stability considerations
Hydrolysis, oxidation, photolysis, physical changes
52
RESIDUE RECOVERY STUDIES
PROBLEM: Is residue able to be quantitavely
recovered from surfaces?
Product
P d t contact
t t materials
t i l
High % of total surface area identify all areas to be sampled
Obtain representative coupons from equipment fabricators
Order coupons with new equipment
Recovery should be consistent and high (e.g., >50%)
Recovery
y factor used in calculations
Multiple approaches
Done in lab by lab personnel consideration for future training
ANALYSIS IS MEANINGLESS
WITHOUT RECOVERY STUDIES
53
RESIDUE RECOVERY STUDIES
C
Case study
t d
Tablet formulation, stable API, all processing on stainless steel except
compressing machine (cast iron)
Stainless steel recovery = 100%
Audit identified no recovery on cast iron
54
RESIDUE RECOVERY STUDIES
Caution with plastics, resins, porous materials.
Obtain materials from equipment fabricators
Material composition
Material porousity
Surface roughness
Example: % Recovery
Neoprene smooth 79.4%
Neoprene rough 11.7%
Reference: Forsyth. J. Validation Technology, Vol15, #4, 2009.
55
RECOVERY STUDIES -- CALCULATION
Recovery data = 50% recovery
= 0.5 recovery factor
56
SWAB SAMPLING TECHNIQUE, RELIABILITY,
AND TRAINING
PROBLEM
PROBLEM:
Swab sampling must recover product residue.
Sampling personnel must be trained and qualified
qualified.
Periodic retraining should be considered.
57
ANALYTICAL METHOD DEVELOPMENT
Sampling methods
Sampling (swab) critical activity
Training program
Trained sampling personnel
Demonstrated acceptable performance
Documented training and retraining
Worst case compounds / procedures in training
Volatile solvents
Problem: Solvents evaporate quickly = false negative
Worst case sampling equipment
Extension poles
58
ANALYTICAL METHODOLOGY
Interface
Biotech tank
59
SAMPLING PERSONNEL TRAINING
Retraining considerations
Who does sampling?
Personnel skills
60
SUMMARY
Cleaning personnel identified frequent
overlooked problems.
Residue
Equipment
E i t
Process
Analytical
61
WHICH ARE MOST IMPORTANT?
Risk analysis
Type (potency) of drug in facility?
Multi-product facility multi use equipment?
Matrix?
Manual cleaning?
SOP cleaning processes how detailed? Signatures?
Analytical recovery?
Swab sampling by trained personnel?
63
FUTURE DEFICIENCY
Lifecycle approach requires ongoing
monitoring of processes
Cleaning processes must be periodically
reviewed ((~2 yyears?))
Review deviations
Review non-conformities
non conformities
Review re-cleans
Management awareness
Improvement projects
64
REFERENCES
LeBlanc, Destin A.
Validated Cleaning Technologies for Pharmaceutical Manufacturing. Interpharm/CRC Press,
2000.
Cleaning Validation Practical Compliance Solutions for Pharmaceutical Manufacturing. PDA
andd DHI Publishing,
P bli hi 2006.
2006
Cleaning Validation Practical Compliance Solutions for Pharmaceutical Manufacturing, Volume
2. PDA and DHI Publishing, 2010.
www.cleaningvalidation.com
Pluta, Paul L., editor. Cleaning and Cleaning Validation, Volume 1. Basics, Expectations, and
Principles. PDA and DHI Publishing, 2009.
Pluta, Paul L., editor. Cleaning and Cleaning Validation, Volume 2. Application of Basics, and
Principles. PDA and DHI Publishing, 2013.
K di k C
Kendrick, Canhuto,
h t and dKKreuze. A
Analysis
l i off D
Degradation
d ti P Products
d t off Bi
Biopharmaceutical
h ti l API C
Caused
d
by Cleaning Agents and Temperature. Journal of Validation Technology, V15, #3, Summer 2009.
Cleaning Validation Forum. Coordinated by Jennifer Carlson. Journal of GXP Compliance.
New Perspectives on Cleaning: Coordinated by Rizwan Sharnez. Journal of Validation Technology.
Pluta and Sharnez. Avoiding Pitfalls in Cleaning Validation. Journal of GXP Compliance, V 14, #3,
Summer 2010.
65
PAUL L. PLUTA, PhD
Editor-in-Chief
Journal of Validation Technology
Journal of GXP Compliance
Advanstar Communications, Iselin, NJ, USA
Adjunct Associate Professor
University of Illinois at Chicago (UIC) College of Pharmacy
Chicago, IL, USA
Editor and Chapter Author
Cleaning and Cleaning Validation, Volume 1. Basics, Expectations, and
Principles, 2009
Cleaning and Cleaning Validation, Volume 2. Application of Basics and
Principles 2013
Principles,
PDA and Davis Healthcare International (DHI) Publishing
Contact: paul.pluta@comcast.net
66